Quagen Drug Patent Portfolio
Quagen owns 4 orange book drugs protected by 8 US patents Given below is the list of Quagen's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8460641 | Microemulsion process and composition | 05 Nov, 2028 | Active |
| US8962000 | Microemulsion and sub-micron emulsion process and compositions | 31 Aug, 2025 | Expired |
| US7141237 | Pharmaceutical foam | 03 Feb, 2024 | Expired |
| US7374747 | Pharmaceutical foam | 23 Jan, 2024 | Expired |
| US6730288 | Mousse composition | 08 Sep, 2019 | Expired |
| US7029659 | Mousse composition | 08 Sep, 2019 | Expired |
| US7078058 | Corticosteroid-containing pharmaceutical composition | 24 May, 2017 | Expired |
| US6126920 | Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition | 01 Mar, 2016 | Expired |
Latest Legal Activities on Quagen's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Quagen.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 22 Nov, 2024 | US8460641 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Jul, 2022 | US8962000 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Sep, 2020 | US8460641 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 22 Oct, 2019 | US7374747 |
|
Expire Patent
Critical
| 13 Aug, 2018 | US7078058 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 16 Jul, 2018 | US8962000 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Apr, 2018 | US7141237 |
|
Maintenance Fee Reminder Mailed
Critical
| 26 Feb, 2018 | US7078058 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 14 Sep, 2017 | US7029659 (Litigated) |
| Application ready for PDX access by participating foreign offices | 31 Aug, 2015 | US8962000 |
| Post Issue Communication - Certificate of Correction | 04 May, 2015 | US8962000 |
| Patent Issue Date Used in PTA Calculation | 24 Feb, 2015 | US8962000 |
| Recordation of Patent Grant Mailed | 24 Feb, 2015 | US8962000 |
| Email Notification | 05 Feb, 2015 | US8962000 |
| Issue Notification Mailed | 04 Feb, 2015 | US8962000 |
Quagen Drug Patents' Oppositions Filed in EPO
Quagen drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on May 14, 2014, by Generics [Uk] Limited. This opposition was filed on patent number EP05775966A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP05775966A | May, 2014 | Henkel AG & Co. KGaA | Patent maintained as amended |
| EP05775966A | May, 2014 | Generics [UK] Limited | Patent maintained as amended |
Quagen's Family Patents
Quagen Drug List
Given below is the complete list of Quagen's drugs and the patents protecting them.
1. Evoclin
Evoclin is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7141237 | Pharmaceutical foam |
03 Feb, 2024
(2 years ago)
| Expired |
| US7374747 | Pharmaceutical foam |
23 Jan, 2024
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Evoclin's drug page
2. Luxiq
Luxiq is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7078058 | Corticosteroid-containing pharmaceutical composition |
24 May, 2017
(9 years ago)
| Expired |
| US6126920 | Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition |
01 Mar, 2016
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Luxiq's drug page
3. Olux
Olux is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6126920 | Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition |
01 Mar, 2016
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Olux's drug page
4. Olux E
Olux E is protected by 4 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8460641 | Microemulsion process and composition |
05 Nov, 2028
(2 years from now)
| Active |
| US8962000 | Microemulsion and sub-micron emulsion process and compositions |
31 Aug, 2025
(11 months ago)
| Expired |
| US6730288 | Mousse composition |
08 Sep, 2019
(6 years ago)
| Expired |
| US7029659 | Mousse composition |
08 Sep, 2019
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Olux E's drug page